GBP Capital provides venture funding and assistance to early and mid-stage life science companies.
GBP Capital provides venture funding and assistance to early and mid-stage life science companies. They target companies with novel approaches to diagnostics, therapeutics, and medical devices, that will change the face of healthcare innovation in the future. They share the drive and vision of their portfolio companies to collaborate with them in accelerating growth and building successful business ventures.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Feb 27, 2008
MabVax Therapeutics
|
Series A | $8M | Biotechnology | Yes |
Nov 3, 2007
Spectral Image
|
Series A | $5M | Health Care | Yes |
GBP Capital has had 1 exits. GBP Capital most notable exits include MabVax Therapeutics
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Jul 11, 2018 | MabVax Therapeutics | IPO | Biotechnology | Detail |